- Home
- NSA vs ADPT Comparison
NSA vs ADPT Comparison
Compare NSA & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSA | ADPT |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NSA | ADPT |
|---|---|---|
| Price | $33.88 | $17.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $32.50 | $16.60 |
| AVG Volume (30 Days) | 1.5M | ★ 2.1M |
| Earning Date | 02-25-2026 | 02-10-2026 |
| Dividend Yield | ★ 6.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $741,511,000.00 | $252,754,000.00 |
| Revenue This Year | N/A | $50.86 |
| Revenue Next Year | $1.11 | $0.53 |
| P/E Ratio | $55.12 | ★ N/A |
| Revenue Growth | N/A | ★ 42.57 |
| 52 Week Low | $27.43 | $6.26 |
| 52 Week High | $40.62 | $20.76 |
Technical Indicators
Market Signals| Indicator | NSA | ADPT |
|---|---|---|
| Relative Strength Index (RSI) | 80.17 | 55.74 |
| Support Level | $31.02 | $15.45 |
| Resistance Level | $32.24 | $18.39 |
| Average True Range (ATR) | 0.89 | 0.84 |
| MACD | 0.61 | 0.15 |
| Stochastic Oscillator | 99.46 | 68.50 |
Price Performance
Historical ComparisonAbout NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).